Quartz Partners’s Bristol-Myers Squibb BMY Stock Holding History

Quartz Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$283K	Buy	+4,539	New	+$287K	0.09%	172

Other funds holding BMY

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Quartz Partners's BMY Position: Q3 2026 in Review

Quartz Partners opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 4,539 shares worth $283K. The stake represents 0.09% of the portfolio and ranks #172 among its holdings.

1,727 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Quartz Partners held 4,539 shares of Bristol-Myers Squibb worth $283K as of Q3 2026.
Bristol-Myers Squibb was a new Quartz Partners position in Q3 2026.
Bristol-Myers Squibb made up 0.09% of Quartz Partners's portfolio in Q3 2026, its #172 holding.
1,727 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Quartz Partners's 13F filing for Q3 2026, filed 3 Nov 2026.